首页 | 本学科首页   官方微博 | 高级检索  
检索        

2010—2012年某院调节血脂药应用分析
引用本文:杨敏,邓思敏,曾燕,曾明辉.2010—2012年某院调节血脂药应用分析[J].中国医院用药评价与分析,2013(6):519-521.
作者姓名:杨敏  邓思敏  曾燕  曾明辉
作者单位:四川省邛崃市医疗中心医院药学部,四川邛崃611530
摘    要:目的:了解某院调节血脂药的使用情况,为促进临床合理用药提供参考。方法:收集2010—2012年某院临床调节血脂药的用量及销售金额,计算其年增长率;以世界卫生组织推荐的限定日剂量(DDD)为基础计算该类药的用药频度(DDDs)、限定日费用(DDC),并进行统计、分析。结果:2010—2012年该院调节血脂药用量及销售金额逐年上升,他汀类药占主导地位,其中阿托伐他汀年均增幅最大。结论:2010—2012年该院调节血脂药的应用呈递增趋势,他汀类是临床调节血脂药的首选,符合我国高脂血症发病的增长趋势。

关 键 词:调节血脂药  用药频度  分析

Analysis of Utilization of Lipid-regulating Drugs in A Hospital During 2010-2012
YANG Min,DENG Si-min,ZENG Yan,ZENG Ming-hui.Analysis of Utilization of Lipid-regulating Drugs in A Hospital During 2010-2012[J].Evaluation and Analysis of Drug-Use in Hospital of China,2013(6):519-521.
Authors:YANG Min  DENG Si-min  ZENG Yan  ZENG Ming-hui
Institution:( Dept. of Pharmacy, Sichuan Qionglai Medical Center Hospital, Sichuan Qionglai 611530, China)
Abstract:OBJECTIVE : To investigate the utilization of lipid-regulating drugs in a hospital for clinical reference of promoting rational use of drugs. METHODS: The lipid-regulating drugs used in a hospital during 2010-2012 period were analyzed statistically with regard to consumption amount, consumption sum, annual incremental rate, DDDs, defined daily dose costs (DDC) using DDD method recommended by WHO. RESULTS: The consumption amount, consumption sum of lipid-regulating drugs increased year by year, with statins showing predominant position and atorvastatin showing the greatest increase. CONCLUSION: The utilization of lipid-regulating drugs in this hospital during 2010-2012 period showed an upward trend, and statins was the first choice of lipid-regulating drugs clinically, which was in conformity with the increasing trend of the morbidity of hypedipidemia.
Keywords:Lipid-regulating drugs  DDDs  Analysis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号